Niagen Bioscience, Inc. (NAGE) Shareholders Equity

Annual Shareholders Equity:

$46.09M+$17.64M(+61.98%)
December 31, 2024

Summary

  • As of today, NAGE annual stockholders equity is $46.09 million, with the most recent change of +$17.64 million (+61.98%) on December 31, 2024.
  • During the last 3 years, NAGE annual shareholders equity has risen by +$14.37 million (+45.28%).
  • NAGE annual shareholders equity is now -14.38% below its all-time high of $53.83 million, reached on December 1, 2017.

Performance

NAGE Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEbalance sheet metrics

Quarterly Shareholders Equity:

$70.68M+$6.48M(+10.10%)
September 30, 2025

Summary

  • As of today, NAGE quarterly stockholders equity is $70.68 million, with the most recent change of +$6.48 million (+10.10%) on September 30, 2025.
  • Over the past year, NAGE quarterly shareholders equity has increased by +$36.31 million (+105.64%).
  • NAGE quarterly shareholders equity is now at all-time high.

Performance

NAGE Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

NAGE Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+62.0%+105.6%
3Y3 Years+45.3%+236.2%
5Y5 Years+125.5%+262.7%

NAGE Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+62.0%at high+236.2%
5Y5-Yearat high+180.7%at high+330.3%
All-TimeAll-Time-14.4%>+9999.0%at high>+9999.0%

NAGE Shareholders Equity History

DateAnnualQuarterly
Sep 2025
-
$70.68M(+10.1%)
Jun 2025
-
$64.19M(+16.0%)
Mar 2025
-
$55.34M(+20.1%)
Dec 2024
$46.09M(+62.0%)
$46.09M(+34.1%)
Sep 2024
-
$34.37M(+11.9%)
Jun 2024
-
$30.72M(+6.1%)
Mar 2024
-
$28.95M(+1.7%)
Dec 2023
$28.46M(-0.8%)
-
Dec 2023
-
$28.46M(+4.2%)
Sep 2023
-
$27.31M(+0.6%)
Jun 2023
-
$27.15M(-3.1%)
Mar 2023
-
$28.02M(-2.3%)
Dec 2022
$28.67M(-9.6%)
$28.67M(+36.4%)
Sep 2022
-
$21.02M(+1.2%)
Jun 2022
-
$20.78M(-19.7%)
Mar 2022
-
$25.88M(-18.4%)
Dec 2021
$31.73M(+93.2%)
$31.73M(-10.5%)
Sep 2021
-
$35.45M(-15.9%)
Jun 2021
-
$42.14M(-3.9%)
Mar 2021
-
$43.83M(+166.9%)
Dec 2020
$16.42M(-19.7%)
$16.42M(-15.7%)
Sep 2020
-
$19.49M(-9.7%)
Jun 2020
-
$21.58M(+30.4%)
Mar 2020
-
$16.55M(-19.1%)
Dec 2019
$20.45M(-24.8%)
$20.45M(-24.7%)
Sep 2019
-
$27.14M(+79.2%)
Jun 2019
-
$15.14M(-27.8%)
Mar 2019
-
$20.98M(-22.8%)
Dec 2018
$27.18M(-49.5%)
$27.18M(-18.6%)
Sep 2018
-
$33.40M(-17.5%)
Jun 2018
-
$40.50M(-13.2%)
Mar 2018
-
$46.66M(-13.3%)
Dec 2017
$53.83M(+439.7%)
$53.83M(+59.6%)
Sep 2017
-
$33.74M(+31.2%)
Jun 2017
-
$25.72M(+174.4%)
Mar 2017
-
$9.37M(-6.0%)
Dec 2016
$9.97M
$9.97M(-15.9%)
Sep 2016
-
$11.86M(-4.7%)
DateAnnualQuarterly
Jun 2016
-
$12.45M(+93.6%)
Mar 2016
-
$6.43M(+21.9%)
Dec 2015
$5.27M(+31.9%)
$5.27M(+21.7%)
Sep 2015
-
$4.34M(+11.3%)
Jun 2015
-
$3.90M(+5.6%)
Mar 2015
-
$3.69M(-7.7%)
Dec 2014
$4.00M(-29.4%)
$4.00M(-11.2%)
Sep 2014
-
$4.50M(+4.3%)
Jun 2014
-
$4.32M(-9.9%)
Mar 2014
-
$4.79M(-15.4%)
Dec 2013
$5.67M(+41.9%)
$5.67M(+73.3%)
Sep 2013
-
$3.27M(-54.6%)
Jun 2013
-
$7.19M(+6.8%)
Mar 2013
-
$6.73M(+68.6%)
Dec 2012
$3.99M(+55.9%)
$3.99M(-23.6%)
Sep 2012
-
$5.23M(-6.7%)
Jun 2012
-
$5.60M(-32.2%)
Mar 2012
-
$8.27M(+222.7%)
Dec 2011
$2.56M(-48.1%)
$2.56M(-43.7%)
Sep 2011
-
$4.55M(+1.7%)
Jun 2011
-
$4.48M(-10.7%)
Mar 2011
-
$5.02M(+1.6%)
Dec 2010
$4.94M(+371.2%)
$4.94M(-3.8%)
Sep 2010
-
$5.13M(-8.0%)
Jun 2010
-
$5.58M(+392.4%)
Mar 2010
-
$1.13M(+8.1%)
Dec 2009
$1.05M(-40.1%)
$1.05M(-5.7%)
Sep 2009
-
$1.11M(-9.9%)
Jun 2009
-
$1.23M(-16.3%)
Mar 2009
-
$1.47M(-15.8%)
Dec 2008
$1.75M(>+9900.0%)
$1.75M(-25.5%)
Sep 2008
-
$2.35M(+16.5%)
Jun 2008
-
$2.01M(>+9900.0%)
Feb 2008
-
-$2700.00(-1450.0%)
Nov 2007
$200.00(-99.5%)
$200.00(-94.6%)
Aug 2007
-
$3700.00(-53.8%)
May 2007
-
$8000.00(-26.6%)
Feb 2007
-
$10.90K
Nov 2006
$38.60K
-

FAQ

  • What is Niagen Bioscience, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. annual shareholders equity year-on-year change?
  • What is Niagen Bioscience, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. quarterly shareholders equity year-on-year change?

What is Niagen Bioscience, Inc. annual stockholders equity?

The current annual shareholders equity of NAGE is $46.09M

What is the all-time high annual shareholders equity for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high annual stockholders equity is $53.83M

What is Niagen Bioscience, Inc. annual shareholders equity year-on-year change?

Over the past year, NAGE annual stockholders equity has changed by +$17.64M (+61.98%)

What is Niagen Bioscience, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of NAGE is $70.68M

What is the all-time high quarterly shareholders equity for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high quarterly stockholders equity is $70.68M

What is Niagen Bioscience, Inc. quarterly shareholders equity year-on-year change?

Over the past year, NAGE quarterly stockholders equity has changed by +$36.31M (+105.64%)
On this page